跳至主要内容
临床试验/ACTRN12614000493640
ACTRN12614000493640已完成2 期

A feasibility study of Integrative medicine for plaque psoriasis combining Chinese herbal medicine with conventional therapy on Psoriasis Area Severity Index (PASI) score and quality of life in people with mild to moderate plaque psoriasis

RMIT University0 个研究点目标入组 30 人开始时间: 2014年5月12日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1 People aged between 18 years and 70 years;
  • 2 People with at least 12 months history of psoriasis vulgaris symptoms diagnosed by physician and where calcipotriol would be appropriate treatment
  • 3 Patient informed consent

排除标准

  • 1 Pregnant or breast feeding females;
  • 2 Type of psoriasis other than vulgaris;
  • 3 PASI score >12 or <7
  • 4 Patients taking systemic drugs or phototherapy for psoriasis within 4 weeks prior to screening;
  • 5 Taking topical drug treatment for psoriasis within 2 weeks prior to screening
  • 6 Other severe disorders;
  • 7 Known disorders of calcium metabolism (high blood calcium levels);
  • 7 Known kidney function disorders.
  • 8 Taking calcium, vitamin D supplements or vitamin D-like medicines.
  • 9 Known sensitivity to Chinese herbs.
  • 10 Known sensitivity to calcipotriol
  • 11 Unwilling/unable to cease other topical and systemic psoriasis related medication use for the duration of the trial.

研究者

相似试验

Integrative medicine for plaque psoriasis combining... | 临床试验